Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia.

Literature DB >> 2545452

Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia.

Abstract

A 19-month-old boy with agammaglobulinaemia contracted a Coxsackie B3 virus infection which caused meningoencephalitis. His neurological status deteriorated over the following 4 years and he died aged 6 years. Treatment with gammaglobulin i.m. and IgG-Fab2 fragments i.v. was not effective. Enterovirus can cause life-threatening infections in immunodeficient patients.

Entities: Disease Species

Mesh：

Year: 1989 PMID： 2545452 DOI： 10.1007/BF00441520

Source DB: PubMed Journal: Eur J Pediatr ISSN： 0340-6199 Impact factor: 3.183

7 in total

1. Intravenous immunoglobulin therapy of progressive encephalitis in X-linked hypogammaglobulinemia.

Authors: E Bernatowska; K Madaliński
Journal: Acta Paediatr Scand Date: 1987-01

2. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia.

Authors: C M Wilfert; R H Buckley; T Mohanakumar; J F Griffith; S L Katz; J K Whisnant; P A Eggleston; M Moore; E Treadwell; M N Oxman; F S Rosen
Journal: N Engl J Med Date: 1977-06-30 Impact factor: 91.245

3. Fatal ECHO 24 infection in a patient with hypogammaglobulinemia: relationship to dermatomyositis-like syndrome.

Authors: J A Bardelas; J A Winkelstein; D S Seto; T Tsai; A D Rogol
Journal: J Pediatr Date: 1977-03 Impact factor: 4.406

4. Coxsackievirus B3 producing fatal meningoencephalitis in a patient with X-linked agammaglobulinemia.

Authors: J B Cooper; W R Pratt; B K English; W T Shearer
Journal: Am J Dis Child Date: 1983-01

5. Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia.

Authors: P J Mease; H D Ochs; R J Wedgwood
Journal: N Engl J Med Date: 1981-05-21 Impact factor: 91.245

6. Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin.

Authors: K Erlendsson; T Swartz; J M Dwyer
Journal: N Engl J Med Date: 1985-02-07 Impact factor: 91.245

7. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child.

Authors: L E Davis; D Bodian; D Price; I J Butler; J H Vickers
Journal: N Engl J Med Date: 1977-08-04 Impact factor: 91.245

7 in total

11 in total

1. Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain.

Authors: J L Bailly; M Chambon; C Henquell; J Icart; H Peigue-Lafeuille
Journal: J Clin Microbiol Date: 2000-02 Impact factor: 5.948

Review 2. Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors: Andreas Dotzauer; Leena Kraemer
Journal: World J Virol Date: 2012-06-12

3. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors: M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal: J Virol Date: 2001-03 Impact factor: 5.103

Review 4. Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors: Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal: Future Microbiol Date: 2010-09 Impact factor: 3.165

5. The role of B lymphocytes in coxsackievirus B3 infection.

Authors: I Mena; C M Perry; S Harkins; F Rodriguez; J Gebhard; J L Whitton
Journal: Am J Pathol Date: 1999-10 Impact factor: 4.307

6. Sequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiency.

Authors: Nadia Driss; Fethi Mellouli; Ahlem Ben Yahia; Henda Touzi; Mohamed-Ridha Barbouche; Henda Triki; Mohamed Bejaoui
Journal: J Clin Microbiol Date: 2014-07-16 Impact factor: 5.948

7. Coxsackievirus B3 infects the bone marrow and diminishes the restorative capacity of erythroid and lymphoid progenitors.

Authors: Nadine Althof; J Lindsay Whitton
Journal: J Virol Date: 2012-12-26 Impact factor: 5.103

8. Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infection.

Authors: Christopher C Kemball; Stephanie Harkins; J Lindsay Whitton
Journal: J Virol Date: 2008-02-27 Impact factor: 5.103

9. Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice.

Authors: Elizaveta Padalko; Erik Verbeken; Patrick Matthys; Joeri L Aerts; Erik De Clercq; Johan Neyts
Journal: BMC Microbiol Date: 2003-12-21 Impact factor: 3.605

10. A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis.

Authors: Fei Wu; Xingjuan Fan; Yan Yue; Sidong Xiong; Chunsheng Dong
Journal: Vaccine Date: 2014-05-27 Impact factor: 3.641